Complication prevention, red flags, adverse events, emergency readiness, and risk tradeoffs.
One comparative RCT with no untreated control, roller physiology data, and the claims with no human evidence at all. Bruising, PIH risk in darker skin, and better…
Botox relaxes the overactive mentalis muscle behind a pebble chin, but no US toxin label mentions the mentalis at all. The one placebo-controlled trial, anatomy, risks,…
An intralesional cortisone shot can flatten an acne cyst within days, but the entire published evidence base is one 1983 trial of 17 patients, and dose drives the dent…
Frequent straightener users had 2.55 times the uterine cancer rate in the Sister Study. Here is what that means in absolute terms, and why FDA still has not banned…
Hooded eyes have three different causes with three different fixes, and only one of them responds to the FDA-approved eye drop. How to tell them apart, and when a droopy…
Beard minoxidil is off-label with narrow evidence: two placebo-controlled RCTs in trans men, a cisgender 3% trial, and a twin study. Real effect sizes, timeline, and…
Vertical lip lines treated by severity: micro-toxin for moving lines, superficial HA fillers for etched lines, laser for elastosis. Approved fillers, real costs, and…
Snail mucin has real but modest human trial evidence: split-face RCT data, an acne combination trial, and industry funding. Rated evidence, dust-mite allergy risk, and…
Dermatology's beef-tallow problem is an evidence vacuum: no controlled trials, a sebum claim that fails lipid chemistry, and financially-biased promotion. What tallow is…
Only two neurotoxins are FDA-approved for crow's feet lines. The on-label units, real cost, duration, eye-area risks, and what to do about lines that stay at rest.